Cadila Healthcare has reported results for second quarter ended September 30, 2018.
The company has reported a rise of 48.18% in its net profit at Rs 666.50 crore for the quarter under review as compared to Rs 449.80 crore for the same quarter in the previous year. Total income of the company increased by 13.77% at Rs 2,054.30 crore for Q2FY19 as compared Rs 1,805.70 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a fall of 17.05% in its net profit at Rs 417.50 crore for the quarter under review as compared to Rs 503.30 crore for the same quarter in the previous year. Total income of the company decreased by 7.79% at Rs 2,991.60 crore for Q2FY19 as compared Rs 3,244.40 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1508.40 |
Dr. Reddys Lab | 6332.85 |
Cipla | 1424.40 |
Zydus Lifesciences | 992.00 |
Lupin | 1663.00 |
View more.. |